Company page

Amplia Therapeutics Ltd.

Amplia Therapeutics Ltd. (ASX: ATX) is a public company based in Australia, focused on developing innovative therapies for cancer and fibrotic diseases. The company is committed to advancing its drug candidates through clinical trials to address unmet medical needs. With a market capitalization of approximately AUD 43.2 million, Amplia is positioned within the biotechnology sector.